The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer

Mohamedtaki A Tejani, Roger B Cohen, Ranee MehraDepartment of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USAAbstract: Recurrent and/or metastatic squamous cell carcinoma of the head and neck (HNSCC) continues to be a source of significant morbidity and mortality worldwide...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mohamedtaki A Tejani, Roger B Cohen, Ranee Mehra
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/70d54dfad4194a2bac2be550248a15c1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares